Aluminium phosphide poisoning
Reading File
Finding Sources
Searching PubMed
"aluminium phosphide" poisoning management
Finding Sources
Reading Article
PMID: 42454906
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
I now have all the information needed for a comprehensive answer. Let me compile it:
Aluminium Phosphide (AlP) Poisoning
Overview
Aluminium phosphide (AlP) is a widely used fumigant and grain preservative, sold under trade names such as Celphos, Alphos, Sulphas, Fumigran, and Phostoxin. It is commonly known as "the agent of sure death." A standard tablet is 3 gm (grayish-green), containing ~56% active ingredient mixed with urea and ammonium carbonate. Each tablet releases 1 gm of phosphine gas (PH3) on contact with moisture.
It is the most important fumigant-type poison in forensic toxicology, especially in India (Punjab, Haryana, UP, Rajasthan), where it is frequently used in suicides, accidental poisonings, and homicidal poisonings (especially in dowry-related deaths in rural settings).
Chemical Reaction (Mechanism of Toxicity)
AlP + 3H₂O → Al(OH)₃ + PH₃ (phosphine)
When the tablet contacts moisture (gastric juice, atmospheric humidity), phosphine gas is liberated. Phosphine is the actual toxic agent.
Cellular mechanism of phosphine:
- Inhibits cytochrome c oxidase (complex IV) in the mitochondrial electron transport chain
- Causes mitochondrial dysfunction and oxidative stress (free radical generation)
- Leads to lipid peroxidation of cell membranes
- Results in multi-organ failure, most prominently the heart and lungs
Fatal Dose and Period
| Parameter | Value |
|---|---|
| Fatal dose | 4-5 gm (1-3 tablets) |
| Fatal period | 12-36 hours |
Signs and Symptoms
The clinical picture is dominated by GI, cardiovascular, and respiratory features:
- GI: Nausea, vomiting, burning epigastric pain, intense thirst, diarrhoea
- Characteristic odor: Garlicky or fishy smell from breath (due to phosphine)
- Respiratory: Tightness in the chest, dyspnoea, severe pulmonary oedema
- CNS: Excitement, agitation, convulsions, coma
- Cardiovascular (most critical):
- Sinus tachycardia, bradycardia, heart block
- Arrhythmias
- Hypotension, shock
- Myocardial damage
- Rarely: pericarditis, congestive cardiac failure
- Metabolic: Hypocalcaemia, tetany, metabolic acidosis, oliguria
- Terminal stage: Cold clammy skin, respiratory distress
- Death occurs due to cardiac failure
Rarely: muscular wasting, bleeding diathesis
Chemical Tests / Bedside Diagnosis
- Ask the patient to breathe on a piece of filter paper impregnated with 0.1 N silver nitrate solution for 5-10 minutes.
- If the paper turns black → phosphine is present in the breath (silver nitrate is reduced to silver by phosphine).
Management
There is NO specific antidote for AlP poisoning. Treatment is supportive.
| Intervention | Detail |
|---|---|
| Gastric lavage | 3-5% sodium bicarbonate, 1% copper sulphate, 1% potassium permanganate, or mineral oil - all convert residual AlP to phosphate within 30 min. (Note: recent studies caution against lavage as moisture promotes more phosphine release in the stomach) |
| Arrhythmia control | Magnesium sulphate - 3 gm IV bolus, then 6 gm infusion over 24 hours for 5-7 days |
| Hypocalcaemia | Calcium salts IV |
| Pulmonary oedema | Corticosteroids |
| Hypotension/shock | Low-dose dopamine infusion |
| Metabolic acidosis | Sodium bicarbonate 50 mEq every 15 min until arterial bicarbonate >15 mmol/L |
| Respiratory support | Oxygen inhalation and artificial respiration |
| Infection | Antibiotics |
Key recent insight (2026 review, PMID: 42454906): Antioxidant therapy is emerging as effective in reducing the effects of AlP poisoning. Supportive therapy remains the mainstay.
Autopsy / Postmortem Findings
- Cyanosis
- Froth over the mouth and nostrils (in some cases)
- Characteristic fishy / garlicky smell on opening the body (phosphine gas)
- All internal organs congested with petechial haemorrhages
- Lungs congested and oedematous (pulmonary oedema well-established)
Medico-Legal Aspects
- Manner: Most cases are suicidal (India: most common suicidal poison in agricultural states); accidental (occupational/farm use); homicidal - frequently in dowry deaths in rural India (the tablet resembles a medicinal preparation, making it easy to conceal and administer).
- AlP is classified as a fumigant under agro-chemicals/pesticide classification.
- Cases rising drastically in Haryana, Punjab, UP, and Rajasthan since the 1980s-90s.
- Hair dye poisoning (Super Vasmol) is now emerging as a competing suicidal agent, particularly in women.
Sources:
- P C Dikshit Textbook of Forensic Medicine and Toxicology, pp. 573-575 (AlP section)
- Parikh's Textbook of Medical Jurisprudence Forensic Medicine and Toxicology, p. 679
- Aghebat-Bekheir et al., Xenobiotica 2026 - most recent review on evolving perspectives and evidence-based management
How does phosphine gas cause oxidative stress and mitochondrial dysfunction at the molecular level?
Finding Sources
Searching PubMed
"phosphine" AND "oxidative stress" AND mitochondria
Reading Article
PMID: 27219283
Reading Article
PMID: 28000313
Reading Article
PMID: 32712815
Reading Article
PMID: 39378909
I now have comprehensive peer-reviewed data. Here is the full molecular-level answer:
Phosphine-Induced Oxidative Stress and Mitochondrial Dysfunction: Molecular Mechanisms
1. The Primary Molecular Target: Cytochrome c Oxidase (Complex IV)
Phosphine gas (PH₃) is a potent inhibitor of cytochrome c oxidase (Complex IV) - the terminal enzyme of the mitochondrial electron transport chain (ETC). This is the central molecular event from which all downstream pathology flows.
Why Complex IV?
Phosphine binds to the copper (CuA and CuB) and iron (heme a and heme a₃) metal centers within Complex IV. These metal centers are essential for accepting electrons from cytochrome c and transferring them to molecular oxygen (O₂) to form water. Phosphine's lone pair of electrons on phosphorus coordinates with these metal centers, blocking electron transfer.
2. Consequences of Complex IV Inhibition
A. Backup of Electrons → Superoxide Generation
When Complex IV is blocked, electrons accumulate upstream in the ETC - particularly at Complex I (NADH dehydrogenase) and Complex III (ubiquinol-cytochrome c reductase). These backed-up electrons leak onto molecular oxygen in a single-electron reduction, forming superoxide radical (O₂•⁻):
O₂ + e⁻ → O₂•⁻
This is the primary source of ROS in AlP poisoning. Superoxide is then rapidly converted to other reactive species:
| Reaction | Product |
|---|---|
| O₂•⁻ + O₂•⁻ + 2H⁺ (via SOD) | H₂O₂ + O₂ |
| H₂O₂ + Fe²⁺ (Fenton reaction) | OH• (hydroxyl radical) + OH⁻ |
| O₂•⁻ + NO• | ONOO⁻ (peroxynitrite) |
These secondary ROS - especially the hydroxyl radical - are far more damaging than superoxide itself and are responsible for the oxidative destruction of cellular components.
B. ATP Depletion
Inhibiting Complex IV halts the proton gradient (ΔΨm) across the inner mitochondrial membrane - the driving force for ATP synthase (Complex V). The result is:
- Rapid fall in intracellular ATP
- Failure of Na⁺/K⁺-ATPase pumps → cellular ion imbalance, depolarization
- Failure of Ca²⁺-ATPase → cytosolic Ca²⁺ overload
In cardiomyocytes, ATP depletion is catastrophic - it directly impairs sarcomeric contraction and relaxation, contributing to the myocardial dysfunction seen clinically.
3. Lipid Peroxidation - Membrane Destruction
Excess ROS (especially OH•) attack the polyunsaturated fatty acids (PUFAs) of membrane phospholipids in a chain reaction:
PUFA → PUFA• (lipid radical) → PUFA-OO• (lipid peroxyl radical) → PUFA-OOH (lipid hydroperoxide)
Key products:
- Malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) - classic biomarkers of lipid peroxidation, elevated in AlP-poisoned patients
- Disruption of the inner mitochondrial membrane itself, further worsening ETC function (a vicious cycle)
- Destruction of red blood cell membranes → hemolysis (as confirmed by Hosseini et al., 2020)
4. Mitochondrial Permeability Transition Pore (mPTP) Opening
Cytosolic Ca²⁺ overload (from ATP-pump failure) + oxidative stress converge on the mitochondrial permeability transition pore (mPTP) - a large non-selective channel in the inner mitochondrial membrane. When opened:
- The mitochondrial membrane potential (ΔΨm) collapses completely
- Mitochondrial matrix swells, outer membrane ruptures
- Cytochrome c is released from the intermembrane space into the cytosol
This is the point of no return for the cell.
5. Apoptosis via the Intrinsic (Mitochondrial) Pathway
Released cytochrome c binds Apaf-1 in the cytosol, forming the apoptosome, which activates caspase-9 → caspase-3 (executioner caspase) → cell death.
The sequence:
PH₃ → Complex IV inhibition
↓
ROS generation + ATP depletion
↓
Ca²⁺ overload + oxidative stress
↓
mPTP opening → Cytochrome c release
↓
Apoptosome → Caspase cascade → Apoptosis
Additionally, the Bcl-2 family is implicated: phosphine-induced ROS shift the balance toward pro-apoptotic members (Bax, Bad) over anti-apoptotic ones (Bcl-2, Bcl-xL), further facilitating cytochrome c release even before full mPTP opening.
6. Why the Heart Is the Primary Target
Several factors make cardiomyocytes uniquely vulnerable:
- Highest mitochondrial density of any cell type (mitochondria occupy ~30% of cardiomyocyte volume)
- Almost entirely dependent on aerobic/oxidative ATP production - virtually no glycolytic reserve
- Continuously active - cannot rest and recover
- High baseline O₂ consumption → more baseline electron flux → more superoxide when the ETC is blocked
This explains why cardiovascular collapse is the primary cause of death in AlP poisoning, not respiratory failure alone.
7. Additional Molecular Targets
Beyond Complex IV, phosphine has been shown to also inhibit:
- Catalase - reduces H₂O₂ breakdown, amplifying oxidative damage
- Cholinesterase - contributes to autonomic dysfunction (though less prominent than in organophosphate poisoning)
- Cytochrome P450 enzymes - impairs hepatic drug metabolism
8. Rational Basis for Antioxidant Therapy
Understanding this pathway explains why antioxidant strategies are the most promising treatments. The 2024 systematic review by Aghebat-Bekheir & Abdollahi identified multiple compounds that target these pathways:
| Agent | Mechanism of Protection |
|---|---|
| Melatonin | Direct ROS scavenger; accumulates in mitochondria; inhibits mPTP opening; blocks cytochrome c release |
| N-acetylcysteine (NAC) | Restores glutathione (GSH), the main intracellular antioxidant |
| Nanocurcumin | Antioxidant + anti-inflammatory |
| Edaravone | Free radical scavenger |
| Acetyl-L-carnitine | Supports mitochondrial fatty acid oxidation and membrane integrity |
| Dihydroxyacetone | Provides alternative metabolic substrate, bypassing blocked ETC |
The 2026 review (PMID: 42454906) confirms antioxidant therapy as the most mechanistically grounded approach currently available.
In summary: Phosphine disrupts cellular respiration at its most terminal step (Complex IV), triggering a cascade of electron leakage → superoxide → lipid peroxidation → membrane failure → Ca²⁺ overload → mPTP opening → apoptosis. This cascade is particularly devastating in the heart, which has no fallback energy pathway when mitochondria fail.
Sources:
- Sciuto et al., Ann N Y Acad Sci 2016 - "Phosphine toxicity: a story of disrupted mitochondrial metabolism"
- Asghari et al., J Pharm Pharmacol 2017 - melatonin review with detailed mPTP/apoptosis mechanism
- Hosseini et al., Cardiovasc Toxicol 2020 - molecular mechanism and cardiovascular pathophysiology
- Aghebat-Bekheir & Abdollahi, Hum Exp Toxicol 2024 - systematic review of cardioprotective treatments
This is a shared conversation. Sign in to Orris to start your own chat.